10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001099800-23-000039 |
| Period End Date | 20230930 |
| Filing Date | 20231027 |
| Fiscal Year | 2023 |
| Fiscal Period | Q3 |
| XBRL Instance | ew-20230930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
102 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$7.90M | USD | Point-in-time |
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$7.90M | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$769.00M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.41B | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Short-term investments (Note 5) |
ShortTermInvestments
|
$453.80M | USD | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Short-term investments (Note 5) |
ShortTermInvestments
|
$446.30M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Accounts receivable, net of allowances of $7.9 and $7.9, respectively |
AccountsReceivableNetCurrent
|
$643.00M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Accounts receivable, net of allowances of $7.9 and $7.9, respectively |
AccountsReceivableNetCurrent
|
$739.80M | USD | Point-in-time |
| Other receivables |
OtherReceivables
|
$56.10M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
1.05B | shares | Point-in-time |
| Other receivables |
OtherReceivables
|
$62.30M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
1.05B | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
649.90M | shares | Point-in-time |
| Inventories (Note 2) |
InventoryNet
|
$875.50M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
646.30M | shares | Point-in-time |
| Inventories (Note 2) |
InventoryNet
|
$1.03B | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
606.50M | shares | Point-in-time |
| Prepaid expenses |
PrepaidExpenseCurrent
|
$110.00M | USD | Point-in-time |
| Prepaid expenses |
PrepaidExpenseCurrent
|
$133.30M | USD | Point-in-time |
| Treasury stock (in shares) |
TreasuryStockCommonShares
|
43.40M | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$195.90M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$235.80M | USD | Point-in-time |
| Treasury stock (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.10B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$4.07B | USD | Point-in-time |
| Long-term investments (Note 5) |
LongTermInvestments
|
$1.24B | USD | Point-in-time |
| Long-term investments (Note 5) |
LongTermInvestments
|
$704.60M | USD | Point-in-time |
| Property, plant, and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.68B | USD | Point-in-time |
| Property, plant, and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.63B | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$90.90M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$92.30M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$1.30B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$1.16B | USD | Point-in-time |
| Other intangible assets, net (Note 7) |
IntangibleAssetsNetExcludingGoodwill
|
$285.20M | USD | Point-in-time |
| Other intangible assets, net (Note 7) |
IntangibleAssetsNetExcludingGoodwill
|
$429.80M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$651.90M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$484.00M | USD | Point-in-time |
| Other assets (Note 6) |
OtherAssetsNoncurrent
|
$447.40M | USD | Point-in-time |
| Other assets (Note 6) |
OtherAssetsNoncurrent
|
$299.10M | USD | Point-in-time |
| Total assets |
Assets
|
$9.37B | USD | Point-in-time |
| Total assets |
Assets
|
$8.29B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$190.60M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$201.90M | USD | Point-in-time |
| Accrued and other liabilities (Note 2) |
AccruedAndOtherLiabilitiesCurrent
|
$795.00M | USD | Point-in-time |
| Accrued and other liabilities (Note 2) |
AccruedAndOtherLiabilitiesCurrent
|
$1.02B | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$25.50M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$24.30M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.24B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.02B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$596.30M | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$596.80M | USD | Point-in-time |
| Contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
- | USD | Point-in-time |
| Contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
$26.20M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrentAndNoncurrent
|
$143.40M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrentAndNoncurrent
|
$81.20M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$70.00M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$69.50M | USD | Point-in-time |
| Uncertain tax positions |
LiabilityForUncertainTaxPositionsNoncurrent
|
$267.50M | USD | Point-in-time |
| Uncertain tax positions |
LiabilityForUncertainTaxPositionsNoncurrent
|
$312.10M | USD | Point-in-time |
| Litigation settlement accrual |
LitigationReserveNoncurrent
|
$104.40M | USD | Point-in-time |
| Litigation settlement accrual |
LitigationReserveNoncurrent
|
$143.00M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$240.30M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$217.50M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$2.64B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$2.49B | USD | Point-in-time |
| Commitments and contingencies (Note 12) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 12) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 649.9 and 646.3 shares issued, and 606.5 and 608.3 shares outstanding, respectively |
CommonStockValue
|
$646.30M | USD | Point-in-time |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 649.9 and 646.3 shares issued, and 606.5 and 608.3 shares outstanding, respectively |
CommonStockValue
|
$649.90M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.97B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$2.21B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$8.62B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$7.59B | USD | Point-in-time |
| Accumulated other comprehensive loss (Note 13) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-250.10M | USD | Point-in-time |
| Accumulated other comprehensive loss (Note 13) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-254.90M | USD | Point-in-time |
| Treasury stock, at cost, 43.4 and 38.0 shares, respectively |
TreasuryStockCommonValue
|
$4.14B | USD | Point-in-time |
| Treasury stock, at cost, 43.4 and 38.0 shares, respectively |
TreasuryStockCommonValue
|
$4.58B | USD | Point-in-time |
| Total Edwards Lifesciences Corporation stockholders' equity |
StockholdersEquity
|
$5.81B | USD | Point-in-time |
| Total Edwards Lifesciences Corporation stockholders' equity |
StockholdersEquity
|
$6.66B | USD | Point-in-time |
| Noncontrolling interest (Note 7) |
MinorityInterest
|
$69.60M | USD | Point-in-time |
| Noncontrolling interest (Note 7) |
MinorityInterest
|
- | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.73B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.22B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$8.29B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$9.37B | USD | Point-in-time |
Income Statement
84 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$4.47B | USD | 3 Qtrs |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.48B | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.32B | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$4.03B | USD | 3 Qtrs |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$253.80M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$822.50M | USD | 3 Qtrs |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$350.40M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$1.02B | USD | 3 Qtrs |
| Gross profit |
GrossProfit
|
$1.07B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$3.21B | USD | 3 Qtrs |
| Gross profit |
GrossProfit
|
$1.13B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$3.45B | USD | 3 Qtrs |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$377.30M | USD | 1 Quarter |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$1.16B | USD | 3 Qtrs |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$439.60M | USD | 1 Quarter |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$1.34B | USD | 3 Qtrs |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$233.60M | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$270.30M | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$713.00M | USD | 3 Qtrs |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$801.80M | USD | 3 Qtrs |
| Intellectual property agreement and litigation expense (income), net (Note 3) |
LitigationSettlementExpense
|
$2.20M | USD | 1 Quarter |
| Intellectual property agreement and litigation expense (income), net (Note 3) |
LitigationSettlementExpense
|
$-2.40M | USD | 1 Quarter |
| Intellectual property agreement and litigation expense (income), net (Note 3) |
LitigationSettlementExpense
|
$193.60M | USD | 3 Qtrs |
| Intellectual property agreement and litigation expense (income), net (Note 3) |
LitigationSettlementExpense
|
$10.80M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
- | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-36.30M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.20M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-12.50M | USD | 1 Quarter |
| Special charge (Note 4) |
OtherNonrecurringIncomeExpense
|
$66.80M | USD | 3 Qtrs |
| Special charge (Note 4) |
OtherNonrecurringIncomeExpense
|
$66.80M | USD | 1 Quarter |
| Special charge (Note 4) |
OtherNonrecurringIncomeExpense
|
- | USD | 1 Quarter |
| Special charge (Note 4) |
OtherNonrecurringIncomeExpense
|
- | USD | 3 Qtrs |
| Operating income, net |
OperatingIncomeLoss
|
$1.13B | USD | 3 Qtrs |
| Operating income, net |
OperatingIncomeLoss
|
$418.40M | USD | 1 Quarter |
| Operating income, net |
OperatingIncomeLoss
|
$402.40M | USD | 1 Quarter |
| Operating income, net |
OperatingIncomeLoss
|
$1.30B | USD | 3 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$15.10M | USD | 1 Quarter |
| Interest income, net |
InterestIncomeExpenseNet
|
$32.80M | USD | 3 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$8.40M | USD | 3 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$6.90M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$-1.00M | USD | 3 Qtrs |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$-2.00M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$5.80M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$9.60M | USD | 3 Qtrs |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$1.31B | USD | 3 Qtrs |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$439.30M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$407.30M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$1.18B | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$146.70M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$184.60M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$63.80M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$55.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$383.70M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.03B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$343.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.12B | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interest (Note 7) |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.80M | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interest (Note 7) |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest (Note 7) |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.20M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest (Note 7) |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$343.50M | USD | 1 Quarter |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$384.90M | USD | 1 Quarter |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$1.03B | USD | 3 Qtrs |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$1.12B | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.63 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.55 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.81 | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.70 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.55 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.79 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.69 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.63 | USD | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
607.20M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
619.80M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
621.00M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
607.00M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
609.50M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
624.50M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
610.20M | shares | 3 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
626.90M | shares | 3 Qtrs |
Cash Flow Statement
86 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$1.03B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$343.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.12B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$383.70M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$104.20M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$108.20M | USD | 3 Qtrs |
| Non-cash operating lease cost |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$20.60M | USD | 3 Qtrs |
| Non-cash operating lease cost |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$20.70M | USD | 3 Qtrs |
| Stock-based compensation (Note 10) |
ShareBasedCompensation
|
$108.90M | USD | 3 Qtrs |
| Stock-based compensation (Note 10) |
ShareBasedCompensation
|
$98.90M | USD | 3 Qtrs |
| Impairment charge (Note 4) |
AssetImpairmentCharges
|
- | USD | 3 Qtrs |
| Impairment charge (Note 4) |
AssetImpairmentCharges
|
$55.10M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.20M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
- | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-36.30M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 8) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-12.50M | USD | 1 Quarter |
| Loss on investments, net |
GainLossOnInvestments
|
$-4.40M | USD | 3 Qtrs |
| Loss on investments, net |
GainLossOnInvestments
|
$-49.10M | USD | 3 Qtrs |
| Deferred income taxes |
IncreaseDecreaseInDeferredIncomeTaxes
|
$148.70M | USD | 3 Qtrs |
| Deferred income taxes |
IncreaseDecreaseInDeferredIncomeTaxes
|
$180.70M | USD | 3 Qtrs |
| Other |
OtherNoncashIncomeExpense
|
$-5.50M | USD | 3 Qtrs |
| Other |
OtherNoncashIncomeExpense
|
$-4.40M | USD | 3 Qtrs |
| Accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$83.00M | USD | 3 Qtrs |
| Accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$123.00M | USD | 3 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$189.70M | USD | 3 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$151.10M | USD | 3 Qtrs |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$112.60M | USD | 3 Qtrs |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-55.70M | USD | 3 Qtrs |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$8.80M | USD | 3 Qtrs |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$106.30M | USD | 3 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-20.30M | USD | 3 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$63.70M | USD | 3 Qtrs |
| Intellectual property agreement accrual |
IncreaseDecreaseInLegalSettlementAccrual
|
$-26.00M | USD | 3 Qtrs |
| Intellectual property agreement accrual |
IncreaseDecreaseInLegalSettlementAccrual
|
$-36.10M | USD | 3 Qtrs |
| Long-term prepaid royalties (Note 3) |
IncreaseDecreaseInPrepaidRoyalties
|
- | USD | 3 Qtrs |
| Long-term prepaid royalties (Note 3) |
IncreaseDecreaseInPrepaidRoyalties
|
$111.90M | USD | 3 Qtrs |
| Other |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$14.80M | USD | 3 Qtrs |
| Other |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$39.70M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$759.20M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$935.40M | USD | 3 Qtrs |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$164.70M | USD | 3 Qtrs |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$175.70M | USD | 3 Qtrs |
| Purchases of held-to-maturity investments (Note 5) |
PaymentsToAcquireHeldToMaturitySecurities
|
$285.50M | USD | 3 Qtrs |
| Purchases of held-to-maturity investments (Note 5) |
PaymentsToAcquireHeldToMaturitySecurities
|
$23.50M | USD | 3 Qtrs |
| Proceeds from held-to-maturity investments (Note 5) |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$324.50M | USD | 3 Qtrs |
| Proceeds from held-to-maturity investments (Note 5) |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$91.50M | USD | 3 Qtrs |
| Purchases of available-for-sale investments (Note 5) |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$302.80M | USD | 3 Qtrs |
| Purchases of available-for-sale investments (Note 5) |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$8.40M | USD | 3 Qtrs |
| Proceeds from available-for-sale investments (Note 5) |
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
$761.10M | USD | 3 Qtrs |
| Proceeds from available-for-sale investments (Note 5) |
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
$486.90M | USD | 3 Qtrs |
| Business combination, net of cash (Note 7) |
PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions
|
- | USD | 3 Qtrs |
| Business combination, net of cash (Note 7) |
PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions
|
$141.20M | USD | 3 Qtrs |
| Payment for acquisition options (Note 6) |
OtherPaymentsToAcquireBusinesses
|
$15.00M | USD | 3 Qtrs |
| Payment for acquisition options (Note 6) |
OtherPaymentsToAcquireBusinesses
|
$107.60M | USD | 3 Qtrs |
| Issuances of notes receivable |
PaymentsToAcquireReceivables
|
$51.50M | USD | 3 Qtrs |
| Issuances of notes receivable |
PaymentsToAcquireReceivables
|
$47.50M | USD | 3 Qtrs |
| Collections of notes receivable |
ProceedsFromCollectionOfNotesReceivable
|
- | USD | 3 Qtrs |
| Collections of notes receivable |
ProceedsFromCollectionOfNotesReceivable
|
$18.00M | USD | 3 Qtrs |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$22.90M | USD | 3 Qtrs |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$18.40M | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$159.70M | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$157.60M | USD | 3 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$861.10M | USD | 3 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$431.20M | USD | 3 Qtrs |
| Proceeds from stock plans |
ProceedsFromStockPlans
|
$136.70M | USD | 3 Qtrs |
| Proceeds from stock plans |
ProceedsFromStockPlans
|
$118.90M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-3.30M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-3.90M | USD | 3 Qtrs |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-297.80M | USD | 3 Qtrs |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-746.10M | USD | 3 Qtrs |
| Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.20M | USD | 3 Qtrs |
| Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$37.40M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$384.30M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$641.30M | USD | 3 Qtrs |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$867.40M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.25B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.41B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$772.60M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period (Note 2) |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.41B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period (Note 2) |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$867.40M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period (Note 2) |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.25B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period (Note 2) |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$772.60M | USD | Point-in-time |
Stockholders Equity
58 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, beginning balance (in shares) |
CommonStockSharesOutstanding
|
606.50M | shares | Point-in-time |
| Common stock, beginning balance (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.73B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.22B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Treasury stock, beginning balance (in shares) |
TreasuryStockCommonShares
|
43.40M | shares | Point-in-time |
| Treasury stock, beginning balance (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
| Net income |
ProfitLoss
|
$383.70M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.12B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$343.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.03B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-100.00K | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-37.80M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-28.90M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-500.00K | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-31.60M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$5.40M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$60.80M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$32.40M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$41.90M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$37.50M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$34.00M | USD | 1 Quarter |
| Common stock issued under stock/equity plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$49.00M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$38.90M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$30.30M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$37.40M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$36.20M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$32.40M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$32.60M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$249.50M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$7.50M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$405.60M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$355.10M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$175.10M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$100.40M | USD | 1 Quarter |
| Changes to noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$-11.60M | USD | 1 Quarter |
| Changes to noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$84.00M | USD | 1 Quarter |
| Common stock, ending balance (in shares) |
CommonStockSharesOutstanding
|
606.50M | shares | Point-in-time |
| Common stock, ending balance (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.22B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.73B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Treasury stock, ending balance (in shares) |
TreasuryStockCommonShares
|
43.40M | shares | Point-in-time |
| Treasury stock, ending balance (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
Comprehensive Income
40 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$1.03B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$343.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.12B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$383.70M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-41.70M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-23.40M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-94.90M | USD | 3 Qtrs |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-31.10M | USD | 3 Qtrs |
| Unrealized gain on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$65.30M | USD | 3 Qtrs |
| Unrealized gain on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$6.30M | USD | 3 Qtrs |
| Unrealized gain on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$18.20M | USD | 1 Quarter |
| Unrealized gain on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$20.60M | USD | 1 Quarter |
| Unrealized pension (costs) credits |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
- | USD | 1 Quarter |
| Unrealized pension (costs) credits |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-100.00K | USD | 3 Qtrs |
| Unrealized pension (costs) credits |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$100.00K | USD | 1 Quarter |
| Unrealized pension (costs) credits |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$200.00K | USD | 3 Qtrs |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-68.50M | USD | 3 Qtrs |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$29.50M | USD | 3 Qtrs |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-10.40M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$10.60M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-31.60M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-98.30M | USD | 3 Qtrs |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$5.40M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$4.80M | USD | 3 Qtrs |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$389.10M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.03B | USD | 3 Qtrs |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$311.90M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.03B | USD | 3 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-1.20M | USD | 1 Quarter |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-2.80M | USD | 3 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$311.90M | USD | 1 Quarter |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$1.03B | USD | 3 Qtrs |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$1.04B | USD | 3 Qtrs |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$390.30M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.